ID: ALA5183187

Max Phase: Preclinical

Molecular Formula: C20H19NO2

Molecular Weight: 305.38

Associated Items:

Representations

Canonical SMILES:  NC(COc1cccc(O)c1)c1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C20H19NO2/c21-20(14-23-19-8-4-7-18(22)13-19)17-11-9-16(10-12-17)15-5-2-1-3-6-15/h1-13,20,22H,14,21H2

Standard InChI Key:  FOAXPHKKCDHLLR-UHFFFAOYSA-N

Associated Targets(non-human)

Glutamate NMDA receptor 6467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.38Molecular Weight (Monoisotopic): 305.1416AlogP: 4.14#Rotatable Bonds: 5
Polar Surface Area: 55.48Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.56CX Basic pKa: 8.71CX LogP: 3.83CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: -0.11

References

1. Karlov DS, Temnyakova NS, Vasilenko DA, Barygin OI, Dron MY, Zhigulin AS, Averina EB, Grishin YK, Grigoriev VV, Gabrel'yan AV, Aniol VA, Gulyaeva NV, Osipenko SV, Kostyukevich YI, Palyulin VA, Popov PA, Fedorov MV..  (2022)  Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity.,  13  (7.0): [PMID:35923717] [10.1039/d2md00001f]

Source